American Institutes for Research to Support Federal Effort to Improve Outcomes for Medicare and Medicaid Recipients with Mental Health or Substance Use Conditions
September 25, 2024 12:00 ET
|
American Institutes for Research
Arlington, Va., Sept. 25, 2024 (GLOBE NEWSWIRE) -- The American Institutes for Research (AIR) has been awarded a contract to help improve the quality of care and physical and behavioral health...
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month
September 25, 2024 08:30 ET
|
PRISM MarketView
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis
DirectRx Pharmacy Announces Promotion to Controller
September 25, 2024 06:10 ET
|
DirectRx Pharmacy
DirectRx Pharmacy announces the promotion of Matthew Elliott to Controller.
Surety Health Brings Profits to Corporations and Newfound NIL Funds to Universities and Colleges
September 24, 2024 18:04 ET
|
Surety Health, Inc.
DELRAY BEACH, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Surety Health, Inc. has recently partnered with Florida Atlantic University (FAU), Boca Raton, FL, a Tier 1 National Research Institution by...
Rimidi Increases Customer Base by 400%, Expands Partnerships and Services in 2024 to Support Future Growth
September 24, 2024 09:00 ET
|
Rimidi
ATLANTA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Rimidi, a market-leading digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease...
Apheresis Equipment Market Set to Hit USD 6.66 Billion By 2032, With a 9.0% CAGR | Polaris Market Research
September 24, 2024 08:10 ET
|
Polaris Market Research & Consulting LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global apheresis equipment market size is predicted to grow from USD 3.08 billion in 2023 to USD 6.66 billion by 2032. It is...
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
September 24, 2024 08:00 ET
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
Noom Calls for Affordable Choices and Fair Pricing of Weight-Loss Medications Ahead of Tuesday’s Senate Testimony
September 24, 2024 07:02 ET
|
Noom Inc
Noom issued a call for public support of a new petition demanding affordable choices and fair pricing for GLP-1 weight-loss medications.
Medical devices, SMEs in healthcare: 4,000 companies at risk of default due to new tax – reports LaPresse
September 23, 2024 11:05 ET
|
LaPresse
ROME, Sept. 23, 2024 (GLOBE NEWSWIRE) -- “In Italy, a regulation imposing a large tax threatens 4,000 companies that supply hospitals and healthcare facilities with essential medical devices,...
Fijoya Selects the Tendo Marketplace to Offer Modular, Cost-Effective Employee Health Benefits
September 23, 2024 10:00 ET
|
Tendo Systems Inc.
Tendo announced today a new partnership with Fijoya, a leading employee benefits platform. The Partnership Streamlines Employer Healthcare with Transparent